1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Structural heart defects

Vutrisiran for treating transthyretin-related amyloidosis cardiomyopathy [ID6470]

In development [GID-TA11598] Expected publication date: 12 November 2025

  • Project information
  • Project documents

28653-Vutrisiran-for-Transthyretin-Amyloid-Cardiomyopathy-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)